Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis

被引：0
作者：
Babayeva, Sabina [1 ]
Dyatlov, Arteni [1 ]
Pallavi, Ranjita [1 ]
Fanucchi, Michael [1 ]
Puccio, Carmelo [1 ]
Lafaro, Rocco [1 ]
Shakil, Fouzia [1 ]
Fallon, John T. [1 ]
Zhong, Minghao [1 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1851
引用
收藏
页码：467A / 467A
页数：1
相关论文
共 50 条
[41]   Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma [J].
Driver, Brandon ;
Miller, Ross A. ;
Deavers, Michael ;
Tacha, David ;
Bernicker, Eric ;
Cagle, Philip T. .
MODERN PATHOLOGY, 2017, 30 :475A-475A
[42]   Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer [J].
Sepesi, Boris ;
Cuentas, Edwin Parra ;
Canales, Jaime Rodriguez ;
Behrens, Carmen ;
Correa, Arlene M. ;
Vaporciyan, Ara ;
Weissferdt, Annikka ;
Kalhor, Neda ;
Moran, Cesar ;
Swisher, Stephen ;
Wistuba, Ignacio .
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (03) :408-415
[43]   Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients [J].
El-Guindy, Dina M. ;
Helal, Duaa S. ;
Sabry, Nesreen M. ;
El-Nasr, Mohamed Abo .
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (04) :125-131
[44]   Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma [J].
Wang, Jennifer ;
Rodriguez, Jaime ;
Rao, Priya ;
Pettaway, Curtis Alvin ;
Pagliaro, Lance C. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
[45]   Safety and clinical activity of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC) [J].
Antonia, Scott ;
Rizvi, Naiyer ;
Brahmer, Julie ;
Ou, Sai-Hong ;
Khleif, Samir N. ;
Hwu, Wen-Jen ;
Gutierrez, Martin ;
Schoffski, Patrick ;
Hamid, Omid ;
Weiss, Jared ;
Lutzky, Jose ;
Maio, Michele ;
Nemunaitis, John ;
Jaeger, Dirk ;
Balmanoukian, Ani ;
Rebelatto, Marlon C. ;
Steele, Keith E. ;
Jin, Xiaoping ;
Robbins, Paul B. ;
Blake-Haskins, John A. ;
Segal, Neil H. .
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
[46]   Non-small cell lung cancers (NSCLC) and programmed death ligand 1 (PD-L1) testing: multicentric analysis of clinical, pathological and molecular features [J].
Elshiekh, M. ;
Mani, A. ;
Kitson, R. ;
Josephides, E. ;
Clifford, A. ;
Desai, S. ;
Gupta, N. ;
Bowen, F. ;
Berry, M. ;
Bloch, S. ;
Ross, C. ;
Counihan, I. ;
Anderson, J. R. ;
Nandi, J. ;
Roddie, M. ;
Copley, S. ;
Hatcher, O. ;
Denton, A. ;
Power, D. ;
Lewanski, C. ;
Newsom-Davis, T. ;
Viola, P. .
LUNG CANCER, 2018, 115 :S52-S53
[47]   Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer [J].
Mitsui, Suguru ;
Tanaka, Yugo ;
Jimbo, Naoe ;
Doi, Takefumi ;
Tane, Shinya ;
Hokka, Daisuke ;
Maniwa, Yoshimasa .
THORACIC CANCER, 2023, 14 (18) :1774-1781
[48]   Correlation of Programmed Cell Death Ligand-1 Messenger RNA and Protein Expression in Non-Small Cell Lung Cancer [J].
Kwon, H. J. ;
Kim, H. ;
Park, S. Y. ;
Park, E. ;
Chung, J. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2243-S2244
[49]   Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer [J].
Wang, Lisha ;
Ren, Fei ;
Wang, Qifeng ;
Baldridge, Lee Ann ;
Monn, M. Francesca ;
Fisher, Kurt W. ;
Sheng, Weiqi ;
Zhou, Xiaoyan ;
Du, Xiang ;
Cheng, Liang .
MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (02) :175-181
[50]   Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer [J].
Lisha Wang ;
Fei Ren ;
Qifeng Wang ;
Lee Ann Baldridge ;
M. Francesca Monn ;
Kurt W. Fisher ;
Weiqi Sheng ;
Xiaoyan Zhou ;
Xiang Du ;
Liang Cheng .
Molecular Diagnosis & Therapy, 2016, 20 :175-181
12345